| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/21/1999 | EP0909167A2 Drug delivery devices and process of manufacture |
| 04/21/1999 | EP0909166A2 Medicated chewing gum with a pleasant taste containing an inclusion complex |
| 04/21/1999 | EP0909165A1 Organised assemblies containing entrapped negatively charged polyelectrolytes |
| 04/21/1999 | EP0909164A1 Instant vesicular product |
| 04/21/1999 | EP0909158A1 Aqueous product comprising oil microdroplets stabilized by in-situ polymerized vinyl monomer and a thickening agent |
| 04/21/1999 | EP0909132A1 Dietetic foods containing conjugated linoleic acids |
| 04/21/1999 | EP0868172A4 Direct compression carbonyl iron tablet |
| 04/21/1999 | EP0748208B1 Cosmetic and/or pharmaceutical preparations |
| 04/21/1999 | EP0690671A4 Method and apparatus for encapsulation of biologically-active substances in cells |
| 04/21/1999 | EP0644785B1 Arrangement for dispensing preservative-free nasal sprays and similar preparations |
| 04/21/1999 | CN2314767Y Novel adhesive plaster |
| 04/21/1999 | CN1214686A Derivatives of camptothecin for use in treating cancer |
| 04/21/1999 | CN1214629A Solid instant-release forms of administration and process for producing the same |
| 04/21/1999 | CN1214243A Preparation method of making undissolved solid medicine preparation become oral liquid |
| 04/20/1999 | US5895789 Salt forms of ketoprofen, ibuprofen, naproxen, and tiaprofenic acid for injections; antiinflammatory agents, analgesics |
| 04/20/1999 | US5895757 Encapsulation of living tissue cells in inorganic microspheres prepared from an organosilicon |
| 04/20/1999 | US5895664 Process for forming quickly dispersing comestible unit and product therefrom |
| 04/20/1999 | US5895663 Pseudoephedrine hydrochloride extended-release tablets |
| 04/20/1999 | US5895662 Meat product pet medicine capsule |
| 04/20/1999 | US5895661 Liposome vesicle precursors |
| 04/20/1999 | US5895660 Deuterated active substances in transdermal application |
| 04/20/1999 | US5895659 Finely dispersed carotenoid and retinoid suspension and their preparation |
| 04/20/1999 | US5895654 Streptococcus equi vaccine |
| 04/20/1999 | US5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists |
| 04/20/1999 | US5895645 Opthalmic solution for artificial tears |
| 04/20/1999 | CA2214895C Improved pharmaceutical composition comprising fenofibrate |
| 04/20/1999 | CA2128230C Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 04/20/1999 | CA2120290C Process for preparing spherules of active agents |
| 04/20/1999 | CA2116524C Antiphlogistic analgesic plastic |
| 04/17/1999 | WO1999020257A1 Hormone replacement therapy drug formulations for topical application to the skin |
| 04/15/1999 | WO1999018159A1 Injection-moldable composition and article of manufacture comprising same |
| 04/15/1999 | WO1999018142A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018119A1 Process for freeze-drying proteins |
| 04/15/1999 | WO1999017868A1 Method for producing a powder product from a liquid substance or mixture of substances |
| 04/15/1999 | WO1999017814A1 Prepolymer compositions comprising an antimicrobial agent |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017780A1 Dexamethasone gel |
| 04/15/1999 | WO1999017774A1 Product and method for the treatment of hyperlipidemia |
| 04/15/1999 | WO1999017771A1 Granular preparations of 5-(2-ethyl- 2h-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine |
| 04/15/1999 | WO1999017766A1 Compressed nitroglycerin tablet and its method of manufacture |
| 04/15/1999 | WO1999017764A1 Medicament containing delta-aminolevulinic acid |
| 04/15/1999 | WO1999017762A1 Concentrate for medical solution and use thereof |
| 04/15/1999 | WO1999017761A1 Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome x |
| 04/15/1999 | WO1999017754A1 Dosage form for aerosol administration |
| 04/15/1999 | WO1999017753A1 Rapidly soluble filmy preparation |
| 04/15/1999 | WO1999017752A1 Improved dosage units |
| 04/15/1999 | WO1999017751A1 Controlled release solid dosage forms of lithium carbonate |
| 04/15/1999 | WO1999017750A1 Method for making a multi-stage drug delivery system |
| 04/15/1999 | WO1999017749A1 A micromachined valve for fluid applications |
| 04/15/1999 | WO1999017748A1 Taste masked pharmaceutical compositions |
| 04/15/1999 | WO1999017747A1 Marking of orally ingested products |
| 04/15/1999 | WO1999017746A1 Process for preparing emulsified powder |
| 04/15/1999 | WO1999017745A1 Monolithic system containing one or more drugs, consisting of three layers with different release mechanisms |
| 04/15/1999 | WO1999017744A1 Immediate release drug delivery forms |
| 04/15/1999 | WO1999017743A1 Dosage forms having improved release properties |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017740A1 Peptide/lipid complex formation by co-lyophilization |
| 04/15/1999 | WO1999017739A1 Aerosol ointment compositions and method of manufacture |
| 04/15/1999 | WO1999017738A1 A prolamine-plant polar lipid composition, its method of preparation and applications thereof |
| 04/15/1999 | WO1999017737A1 Suppository composition |
| 04/15/1999 | WO1999017736A1 Co-ground products for the cosmetic and dermatological use |
| 04/15/1999 | WO1999017612A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | WO1999008666A3 Pharmaceutical composition comprising an azateroid |
| 04/15/1999 | WO1999004821A3 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 04/15/1999 | WO1999004773A3 Method for inhibiting bone resorption |
| 04/15/1999 | WO1999003448A9 Materials and methods for making improved micelle compositions |
| 04/15/1999 | WO1999002142A3 Novel composition comprising an ssri and a beta-blocker |
| 04/15/1999 | WO1999001213A9 Microbeads prepared from cross-linked polysaccharide hydrogel capable of containing molecules of biological interest or cells |
| 04/15/1999 | WO1998058668A3 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
| 04/15/1999 | WO1998053799A3 Immunogenic compositions |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | WO1998029110A3 Formulation and method for treating neoplasms by inhalation |
| 04/15/1999 | DE19745208A1 Pharmaceutical film that dissolves in mouth |
| 04/15/1999 | DE19744811A1 Composition for tumour diagnosis and/or therapy |
| 04/15/1999 | DE19744113A1 Ophthalmological dexamethasone preparation |
| 04/15/1999 | CA2317066A1 A prolamine-plant polar lipid composition, its method of preparation and applications thereof |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2306484A1 Aerosol ointment compositions and method of manufacture |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2305761A1 Composition for suppositories |
| 04/15/1999 | CA2305535A1 Controlled release solid dosage forms of lithium carbonate |
| 04/15/1999 | CA2305190A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304456A1 Prepolymer compositions comprising an antimicrobial agent |
| 04/15/1999 | CA2301569A1 Dosage form for aerosol administration |
| 04/15/1999 | CA2273275A1 Improved dosage units |
| 04/15/1999 | CA2273274A1 Dosage forms having improved release properties |
| 04/14/1999 | EP0908482A1 Aliphatic polyesters of trimethylene carbonate Epsilon-caprolactone and glycolide |
| 04/14/1999 | EP0908178A1 Partial liquid breathing of fluorocarbons |
| 04/14/1999 | EP0908177A1 Procedure to form pharmaceutical compositions in spherical pills or granules of controlled and sustained action that contain as active agent Bromazepam and pharmaceutical compositions obtained by said procedure |
| 04/14/1999 | EP0908176A1 Intravenous administration form of thalidomide for the therapy of immunologic diseases |
| 04/14/1999 | EP0907725A1 A process for encapsulating viable animal cells |
| 04/14/1999 | EP0907681A1 Hydrophobic polymer dispersion and process for the preparation thereof |
| 04/14/1999 | EP0907666A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 04/14/1999 | EP0907365A1 Novel formulation |
| 04/14/1999 | EP0907364A1 Pharmaceutical compositions |
| 04/14/1999 | EP0907359A1 Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems |
| 04/14/1999 | EP0907358A2 Uniform drug delivery therapy |